DiaGenic ASA: Report from Second Quarter 2012
OSLO, Norway--(BUSINESS WIRE)--Regulatory News:
DiaGenic: (OSE:DIAG)
New CEO - progress in Alzheimer’s and Parkinson’s disease
The interim report for the second quarter 2012 was approved by the Board of Directors on 28 August 2012. Please find the interim report and presentation attached. Highlights from the report:
Paul de Potocki announced as new CEO, assumes his position September 17th